Global Blood Glucose Equipment Market Report (2022 to 2027)

DUBLIN May 13, 2022 /PRNewswire/ — The report “Blood Glucose Device Market, Users Global Forecast 2022-2027, SMBG Components, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis” has been added to ResearchAndMarkets.com’s offer.

Logo for research and markets

The report offers a detailed analysis of the Self Monitoring Blood Glucose Meters industry. The global self-monitoring blood glucose device market is expected to rise to: US$46.69 billion in 2027.

Over time, typical diagnostic lab tests have only served to help doctors diagnose disease. In contrast, patients with more fluctuating glucose levels should check their levels every day. Also, patients taking insulin should regularly check their blood glucose levels. As a result, a current approach to diabetes care in which patients use blood glucose meters to immediately monitor their glucose levels and provide an accurate assessment of capillary glucose concentration is known as self-monitoring blood glucose (SMBG). In addition, blood glucose monitoring helps diabetic patients make daily management decisions, such as food consumption, insulin dosing and physical activity.

The self-monitoring blood glucose equipment industry is expected to grow at a CAGR of 4.12% from 2021 to 2027:

The increased prevalence of diabetes is due to the market growth of self-monitoring blood glucose gadgets. In addition, changes in lifestyle, food choices, increased smoking and alcohol consumption will increase the prevalence of diabetes. Again, as people become more aware of home monitoring and the importance of regular diabetes treatment to lower the risk of hyperglycemia, the demand for self-monitoring blood glucose meters is increasing.

In addition, the government is launching several programs to raise public awareness about early diagnosis. The National Diabetes Education Program (NDEP) partnered with the Centers for Disease Control and Prevention (CDC) and the NIH. The National Diabetes Education Program (NDEP) aims to reduce the prevalence of prediabetes by providing diabetes-related education to an eclectic group of people, including hard-to-reach residents, faith communities, ethnic minorities, community organizations and health care providers.

COVID-19 impact on self-monitoring blood glucose device industry:

The COVID-19 epidemic has boosted the growth of the self-monitoring blood glucose devices market. Due to the pandemic, some market parties reported an increase in income from diabetes care. For example, Abbott claimed in June 2020 that their glucose monitoring device FreeStyleLibre accounted for 59.3 percent of the company’s revenue growth in the first quarter of 2020. With the increased risk of coronavirus transmission in diabetic patients, a new focus has been placed on home monitoring devices to help patients regulate their blood glucose levels. According to the publisher, the market for self-monitoring blood glucose devices was: US$36.64 billion for 2021.

Global Self-Monitoring Blood Glucose Devices Market Analysis: Introduction

Self-monitoring blood glucose device industry is divided into type 1 diabetes and type 2 diabetes perspective for diabetes population, blood glucose device market (SMBG) (test strips, lancet, glucose meter), blood glucose device users (SMBG) and reimbursement of blood glucose devices from 17 countries (United StatesUnited KingdomGermanySpainItalyThe NetherlandsNorwaySwedenSwitzerlandAustraliaKuwaitBrazilRussiaIndiaChinaSouth Africaand Saudi Arabia

Competitive landscape:

The leading players in the global blood glucose self-monitoring market are Roche Diagnostic, Abbott Laboratories, Dexcom, Inc., Medtronic, B. Braun Melsungen AG and DarioHealth Corp. According to the data, these companies have a global presence in the market and have a significant share of the market. At the same time, the remaining manufacturers are limited to other local or regional manufacturers. Recent mergers and acquisitions between the participants have helped the companies strengthen their presence in the market.

Main topics covered:

1 Introduction

2. Research and methodology

3. Summary

4. Market Dynamics
4.1 Growth factors
4.2 Challenges

5. Global Blood Glucose (SMBG) Market and Users
5.1 Blood Glucose Device Market (Type 1 + Type 2) Diabetes
5.1.1 Type 1 Diabetes
5.1.2 Type 2 diabetes
5.2 Test Strips Market and Forecast
5.2.1 Type 1 Diabetes
5.2.2 Type 2 diabetes
5.3 Lancet Market and Forecast
5.3.1 Type 1 Diabetes
5.3.2 Type 2 diabetes
5.4 Meter market and forecast
5.4.1 Type 1 Diabetes
5.4.2 Type 2 diabetes
5.5 Global Diabetes Population (Type1 + Type 2)
5.5.1 Type 1 diabetes population
5.5.2 Type 2 diabetes population
5.6 Blood Glucose (SMBG) Device Users (Type1 + Type 2)
5.6.1 Diabetes Blood Glucose (SMBG) Type 1 Users
5.6.2 Diabetes Blood Glucose (SMBG) Type 2 Users

6. Stock Analysis – Blood Glucose Device Market, Diabetes Population, SMBG User
6.1 SMBG . Market Share
6.1.1 Total SMBG market share
6.1.1.1Type 1
6.1.1.2Type 2
6.1.2 Test Strips
6.1.2.1Type 1
6.1.2.2Type 2
6.1.3 Lancet
6.1.3.1Type 1
6.1.3.2 Type 2
6.1.4 Blood Glucose Meter
6.1.4.1Type 1
6.1.4.2 Type 2
6.1.5 Diabetes population share
6.1.5.1 Type 1 diabetes
6.1.5.2 Type 2 Diabetes
6.1.6.1 Type 1 diabetes
6.1.6.2 Type 2 diabetes

7. United States

8. United Kingdom

9. Germany

10. Spain

11. Italy

12. The Netherlands

13. Norway

14. Sweden

15. Switzerland

16. Australia

17. Kuwait

18. Brazil

19. Russia

20. India

21. China

22. South Africa

23. Saudi Arabia

24. Business Analysis
24.1 Roche diagnosis
24.1.1 Overview
24.1.2 Recent developments
24.1.3 Revenue
24.2 Abbott Laboratories
24.2.1 Overview
24.2.2 Recent developments
24.2.3 Revenue
24.3 Dexcom, Inc.
24.3.1 Overview
24.3.2 Recent developments
24.3.3 Revenue
24.4 Medtronic
24.4.1 Overview
24.4.2 Recent developments
24.4.3 Revenue
24.5 B† Braun Melsungen AG
24.5.1 Overview
24.5.2 Recent developments
24.5.3 Yield
24.6 DarioHealth Corp
24.6.1 Overview
24.6.2 Recent developments
24.6.3 Yield

For more information on this report, please visit https://www.researchandmarkets.com/r/glomjp

Media contact:

Research and markets
Laura Woodsenior manager
press@researchandmarkets.com

For EST business hours, call +1-917-300-0470
For US/CAN Toll Free Call +1-800-526-8630
For GMT office hours, please call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

decide

decide

View original content: https://www.prnewswire.com/news-releases/global-blood-glucose-device-market-report-2022-to-2027—key-drivers-and-challenges-301546904.html

SOURCE Research and markets

Leave a Comment